Results 21 to 30 of about 1,283 (170)

Pancreatic Pseudocyst With Thoracic Extension: A Clinicoradiological Case Report. [PDF]

open access: yesClin Case Rep
CECT sagittal view shows an enlarged, heterogeneously enhancing pancreas with a peripancreatic collection extending into the posterior mediastinum and compressing the esophagus with massive right pleural fluid noted. ABSTRACT Pancreatic pseudocysts are encapsulated, enzyme‐rich peripancreatic fluid collections that typically develop following acute or ...
Thapa S   +7 more
europepmc   +2 more sources

Development and validation of a green analytical method to determine bromhexine hydrochloride in pharmaceuticals [PDF]

open access: yesScientific Reports
Erythrosine B (EB) is a food colorant and antiviral xanthene dye that is widely used as a color additive in pharmaceutical and cosmetic industries. Its application as a sensor for spectrophotometric measurement of amine-based pharmaceuticals offers ...
Salwa Kh. Mohamed   +2 more
doaj   +2 more sources

Effect of increasing doses of colchicine on the treatment of 333 COVID‐19 inpatients [PDF]

open access: yesImmunity, Inflammation and Disease
Background Previous research done in Bulgaria demonstrated a fivefold reduction in mortality from COVID‐19 with increased doses of colchicine from two hospitals in the country.
Rumen Tiholov   +5 more
doaj   +2 more sources

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial [PDF]

open access: yesBioImpacts, 2020
Introduction: Bromhexine is a potential therapeutic option in COVID-19, but no data from a randomized clinical trial has been available. The present study aimed to evaluate the efficacy of bromhexine in intensive care unit (ICU) admission, mechanical ...
Khalil Ansarin   +10 more
doaj   +1 more source

Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials

open access: yesВопросы вирусологии, 2022
COVID-19 (novel coronavirus disease 2019), caused by the SARS-CoV-2 virus, has various clinical manifestations and several pathogenic pathways. Although several therapeutic options have been used to control COVID-19, none of these medications have been ...
S. Bahadoram   +6 more
doaj   +1 more source

Spectrophotometric Determination of Bromhexine Hydrochloride by Azo-Dye Formation Reaction [PDF]

open access: yesمجلة التربية والعلم, 2009
A spectrophotometric method for the assay of trace amounts of bromhexine-HCl based on the reaction of bromhexine-HCl with nitrite ion to form the corresponding diazonium salt followed by coupling reaction with pyrogallol in a acidic medium to form a ...
Nabeel Othman, Shilan Omer
doaj   +1 more source

Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib [PDF]

open access: yesPharmacia, 2023
Millions of publications and thousands of clinical trials have not led to the discovery of an effective treatment for COVID-19. We believe that the reason for this is the inaccurate strategy of inhibiting target molecules involved in the pathogenesis of ...
Vanyo Mitev
doaj   +3 more sources

Possibility for the use of bromhexine to prevent infection with SARS-CoV-2

open access: yesКачественная клиническая практика, 2020
The routine use of bromhexine to prevent infection SARS-CoV-2 is not recommended. The use of bromhexine is possible in clinical trials.
K. A. Zagorodnikova   +2 more
doaj   +1 more source

The place of combined mucoactive drugs in the treatment of acute respiratory infections in children

open access: yesМедицинский совет, 2022
The problem of respiratory diseases and their therapy options still retains much of its urgency. Respiratory diseases in children are still super common.
L. S. Starostina
doaj   +1 more source

Home - About - Disclaimer - Privacy